ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients

ClinicalTrials.gov ID: NCT00002446

Public ClinicalTrials.gov record NCT00002446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Controlled Trial of SCH 56592 Oral Suspension Versus Fluconazole Suspension in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

Study identification

NCT ID
NCT00002446
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Schering-Plough
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Fluconazole Drug
  • Posaconazole Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 1998
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

Started 1998

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
East Bay AIDS Ctr Berkeley California 94705
ViRx Inc San Francisco California 94109
Kaiser Foundation Hospital San Francisco California 94118
Infectious Disease and AIDS Clinic Denver Colorado 80204
Dupont Circle Physicians Group Washington D.C. District of Columbia 200091104
Boulevard Comprehensive Care Ctr Jacksonville Florida 32209
Miami Veterans Administration Med Ctr Miami Florida 33125
TRIAD Health Practice Chicago Illinois 60657
Community Hosp Indianapolis Indianapolis Indiana 46219
Wayne State Univ / Harper Hosp Detroit Michigan 48201
UMDNJ - New Jersey Med School / Cooper Hosp Camden New Jersey 08103
Jersey City Med Ctr Jersey City New Jersey 07304
SUNY / Health Science Ctr at Brooklyn Brooklyn New York 11203
Univ of Pennsylvania School of Dental Medicine Philadelphia Pennsylvania 19104
Med Univ of South Carolina Charleston South Carolina 29425
Amelia Ct Clinic Dallas Texas 75235
Univ of Texas Health Sciences Ctr San Antonio Texas 78284

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002446 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →